Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eoin Mulroy

Showing results (81-90 of 101) with videos related to

Pageof 11
Sort By:
Annals of Clinical and Translational Neurology|May 3, 2024
POLR3A-related disorders: From spastic ataxia to generalised dystonia and long-term efficacy of deep brain stimulationWai Yan Yau, Catherine Ashton, Eoin Mulroy, et al.
Neurology|August 6, 2020
Criss-cross gait: A clue to glucose transporter type 1 deficiency syndromeFrancesca Magrinelli, Eoin Mulroy, Susanne A Schneider, et al.
European Journal of Neurology|July 16, 2024
Dysphagia in primary progressive aphasia: Clinical predictors and neuroanatomical basisSalvatore Mazzeo, Eoin Mulroy, Jessica Jiang, et al.
Neurology. Genetics|May 12, 2021
Expanding the Spectrum of Movement Disorders Associated With <i>C9orf72</i> Hexanucleotide ExpansionsCarlos Estevez-Fraga, Francesca Magrinelli, Davina Hensman Moss, et al.
Journal of the Neurological Sciences|May 20, 2021
Development of parkinsonism after long-standing cervical dystonia - A cohortBettina Balint, Eoin Mulroy, Felix Gövert, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|May 2, 2022
Ethnic Differences in Dystonia Prevalence and PhenotypeEoin Mulroy, Antonella Macerollo, Sangeeta Scotton, et al.
Parkinsonism & Related Disorders|December 4, 2018
A phase IIb, randomised, double-blind, placebo-controlled, dose-ranging investigation of the safety and efficacy of NTCELL<sup>®</sup> [immunoprotected (alginate-encapsulated) porcine choroid plexus cells for xenotransplantation] in patients with Parkinson's diseaseBarry Snow, Eoin Mulroy, Arnold Bok, et al.
NPJ Parkinson'S Disease|December 9, 2020
The CloudUPDRS smartphone software in Parkinson's study: cross-validation against blinded human ratersAshwani Jha, Elisa Menozzi, Rebecca Oyekan, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|December 10, 2023
Binary reversals: a diagnostic sign in primary progressive aphasiaEoin Mulroy, Lucy B Core, Anthipa Chokesuwattanaskul, et al.
Parkinsonism & Related Disorders|December 15, 2020
A long-term follow-up of safety and clinical efficacy of NTCELL® [Immunoprotected (Alginate-encapsulated) porcine choroid plexus cells for xenotransplantation] in patients with Parkinson's diseaseEoin Mulroy, Barry Snow, Arnold Bok, et al.
Pageof 11

Showing results (81-90 of 101) with videos related to

Sort By:
Pageof 11
Annals of Clinical and Translational Neurology|May 3, 2024
POLR3A-related disorders: From spastic ataxia to generalised dystonia and long-term efficacy of deep brain stimulationWai Yan Yau, Catherine Ashton, Eoin Mulroy, et al.
Neurology|August 6, 2020
Criss-cross gait: A clue to glucose transporter type 1 deficiency syndromeFrancesca Magrinelli, Eoin Mulroy, Susanne A Schneider, et al.
European Journal of Neurology|July 16, 2024
Dysphagia in primary progressive aphasia: Clinical predictors and neuroanatomical basisSalvatore Mazzeo, Eoin Mulroy, Jessica Jiang, et al.
Neurology. Genetics|May 12, 2021
Expanding the Spectrum of Movement Disorders Associated With <i>C9orf72</i> Hexanucleotide ExpansionsCarlos Estevez-Fraga, Francesca Magrinelli, Davina Hensman Moss, et al.
Journal of the Neurological Sciences|May 20, 2021
Development of parkinsonism after long-standing cervical dystonia - A cohortBettina Balint, Eoin Mulroy, Felix Gövert, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|May 2, 2022
Ethnic Differences in Dystonia Prevalence and PhenotypeEoin Mulroy, Antonella Macerollo, Sangeeta Scotton, et al.
Parkinsonism & Related Disorders|December 4, 2018
A phase IIb, randomised, double-blind, placebo-controlled, dose-ranging investigation of the safety and efficacy of NTCELL<sup>®</sup> [immunoprotected (alginate-encapsulated) porcine choroid plexus cells for xenotransplantation] in patients with Parkinson's diseaseBarry Snow, Eoin Mulroy, Arnold Bok, et al.
NPJ Parkinson'S Disease|December 9, 2020
The CloudUPDRS smartphone software in Parkinson's study: cross-validation against blinded human ratersAshwani Jha, Elisa Menozzi, Rebecca Oyekan, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|December 10, 2023
Binary reversals: a diagnostic sign in primary progressive aphasiaEoin Mulroy, Lucy B Core, Anthipa Chokesuwattanaskul, et al.
Parkinsonism & Related Disorders|December 15, 2020
A long-term follow-up of safety and clinical efficacy of NTCELL® [Immunoprotected (Alginate-encapsulated) porcine choroid plexus cells for xenotransplantation] in patients with Parkinson's diseaseEoin Mulroy, Barry Snow, Arnold Bok, et al.
Pageof 11